View in EDS

52 Specific Pseudomonas aeruginosa IgG levels before and after elexacaftor/tezacaftor/ivacaftor treatment.

Saved in:
Bibliographic Details
Title: 52 Specific Pseudomonas aeruginosa IgG levels before and after elexacaftor/tezacaftor/ivacaftor treatment.
Authors: Bryrup, T. (AUTHOR), Faurholt-Jepsen, D. (AUTHOR), Skov, M. (AUTHOR), Katzenstein, T. (AUTHOR), Mathiesen, I. (AUTHOR), Helweg-Larsen, J. (AUTHOR), Johansen, H. (AUTHOR), Qvist, T. (AUTHOR), Pressler, T. (AUTHOR)
Source: Journal of Cystic Fibrosis. Sep2024 Supplement 2, Vol. 23, pS28-S29. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179396892
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 52 Specific Pseudomonas aeruginosa IgG levels before and after elexacaftor/tezacaftor/ivacaftor treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Bryrup%2C+T%2E%22">Bryrup, T.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Faurholt-Jepsen%2C+D%2E%22">Faurholt-Jepsen, D.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Skov%2C+M%2E%22">Skov, M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Katzenstein%2C+T%2E%22">Katzenstein, T.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mathiesen%2C+I%2E%22">Mathiesen, I.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Helweg-Larsen%2C+J%2E%22">Helweg-Larsen, J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Johansen%2C+H%2E%22">Johansen, H.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qvist%2C+T%2E%22">Qvist, T.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pressler%2C+T%2E%22">Pressler, T.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Cystic+Fibrosis%22">Journal of Cystic Fibrosis</searchLink>. Sep2024 Supplement 2, Vol. 23, pS28-S29. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179396892
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1569-1993(24)00895-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S28
    Titles:
      – TitleFull: 52 Specific Pseudomonas aeruginosa IgG levels before and after elexacaftor/tezacaftor/ivacaftor treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bryrup, T.
      – PersonEntity:
          Name:
            NameFull: Faurholt-Jepsen, D.
      – PersonEntity:
          Name:
            NameFull: Skov, M.
      – PersonEntity:
          Name:
            NameFull: Katzenstein, T.
      – PersonEntity:
          Name:
            NameFull: Mathiesen, I.
      – PersonEntity:
          Name:
            NameFull: Helweg-Larsen, J.
      – PersonEntity:
          Name:
            NameFull: Johansen, H.
      – PersonEntity:
          Name:
            NameFull: Qvist, T.
      – PersonEntity:
          Name:
            NameFull: Pressler, T.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: Sep2024 Supplement 2
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 15691993
          Numbering:
            – Type: volume
              Value: 23
          Titles:
            – TitleFull: Journal of Cystic Fibrosis
              Type: main
ResultId 1